CliniComp International, Inc. v. Cerner Corporation

District Court, S.D. California·Decided March 22, 2023·No. 3:17-cv-02479·Unknown

Opinion

CLINICOMP INTERNATIONAL, INC., Case No.: 17-cv-02479-GPC (DEB)

Plaintiff, ORDER AWARDING DEFENDANT v. ATTORNEYS’ FEES UNDER 35 U.S.C. § 285 Defendant. On February 3, 2023, the Court granted Defendant Cerner Corporation (“Cerner”)’s motion for attorneys’ fees pursuant to 35 U.S.C. § 285; found this case to be “exceptional;” and awarded Cerner its reasonable attorneys’ fees incurred since August 29, 2022. (Dkt. No. 133.) On February 24, 2023, Cerner filed its brief in support of its request for its attorneys’ fees incurred since August 29, 2022. (Dkt. No. 136.) On March 10, 2023, CliniComp filed its response to Cerner’s request for attorneys’ fees. (Dkt. No. 141.) On March 17, 2023, Cerner filed its reply. (Dkt. No. 149.) For the reasons set forth below, the Court awards Cerner $802,334.60 in attorneys’ fees under 35 U.S.C. § 285. CliniComp is the owner of U.S. Patent No. 6,665,647 (“the ’647 Patent”) by assignment. (Dkt. No. 1, Compl. ¶ 2.) In the present action, CliniComp alleged that Cerner directly infringes claims 1, 2, 5, 10-13, 15-18, and 20-23 of the ’647 Patent by making, using, selling, and/or offering to sell within the United States Cerner’s CommunityWorks, PowerWorks, and Lights on Network services (collectively “the accused services”). (Dkt. No. 103, Ex. 2 at 21; see also Dkt. No. 1, Compl. ¶¶ 15-16.) On December 11, 2017, CliniComp filed a complaint for patent infringement against Cerner, alleging infringement of the ’647 Patent. (Dkt. No. 1, Compl.) On May 16, 2018, the Court granted Cerner’s motion to dismiss CliniComp’s claims for willful infringement and indirect infringement as well as the relief sought in connection with these claims of injunctive relief, treble damages, and exceptionality damages. (Dkt. No. 18 at 21.) On June 25, 2018, Cerner filed an answer to CliniComp’s complaint. (Dkt. No. 19.) On March 5, 2019, the Patent Trial and Appeal Board (“PTAB”) instituted an inter partes review (“IPR”) as to claims 1-25 and 50-55 of the ’647 Patent. (Dkt. No. 30-1, Ex. A.) On March 7, 2019, the Court granted a stay of the action pending completion of the IPR proceedings. (Dkt. No. 31.) On March 26, 2020, the PTAB issued a final written decision, determining that claims 50-55 of the ’647 Patent are not patentable in light of the prior art, but that claims 1-25 of the ’647 Patent are patentable.1 (Dkt. No. 32, Ex. A at 93- 94.) On April 20, 2021, the Federal Circuit affirmed the PTAB’s determination that claims 1-25 of the ’647 Patent are patentable.2 (Dkt. No. 38-2, Ex. B at 10.) On June 24, 2021, the Court granted the parties’ joint motion to lift the stay of the action. (Dkt. No. 44.)

1 Specifically, the PTAB concluded that Cerner had shown by a preponderance of the evidence that: (1) claims 50-52 are not patentable based on Evans; (2) claims 53 and 54 are not patentable based on Evans and Rai; (3) claims 50-53, and 55 are not patentable based on Johnson and Evans; and (4) claim 54 is not patentable based on Johnson, Evans, and Rai. (Dkt. No. 32, Ex. A at 93-94.) The PTAB further concluded that Cerner had not shown by a preponderance of the evidence: (1) that claims 1-5, 10-13, and 15-25 are unpatentable based on Johnson and Evans; or (2) that claims 6-9, and 14 are unpatentable based on Johnson, Evans, and Rai. (Id. at 93.) 2 On November 15, 2021, the PTO issued an inter partes review certificate for the ’647 Patent, stating: “Claims 1-25 are found patentable” and “Claims 50-55 are cancelled.” (Dkt. No. 71-2, Ex. A at A-20–A-21.) On July 23, 2021, Cerner filed an amended answer to CliniComp’s complaint. (Dkt. No. 52.) On October 7, 2021, the Court issued a scheduling order for the action. (Dkt. No. 55.) On July 28, 2022, the Court issued a claim construction order, construing the disputed claim terms from the ’647 Patent. (Dkt. No. 91.) On November 15, 2022, the Court granted Cerner’s motion for summary judgment of non-infringement. (Dkt. No. 120.) Specifically, the Court held that Cerner demonstrated that the accused services do not infringe the asserted claims of the ’647 Patent as a matter of law. (Id. at 44.) On November 16, 2022, the Court entered a judgment in the action in favor of Defendant Cerner and against Plaintiff CliniComp. (Dkt. No. 121.) On December 30, 2022, the Clerk of Court taxed costs in favor of Cerner in the amount of $8,265.80. (Dkt. No. 131 at 3.) On February 3, 2023, the Court granted Cerner’s motion for attorneys’ fees pursuant to 35 U.S.C. § 285, and the Court awarded Cerner its reasonable attorneys’ fees incurred since August 29, 2022. (Dkt. No. 133 at 23.) By the present briefing, Cerner requests that the Court award it $802,334.60 for its attorneys’ fees incurred since August 29, 2022. (Dkt. No. 144 at 1, 11; Dkt. No. 149 at 6.) Cerner requests that the Court award it $802,334.60 in attorneys’ fees under the lodestar method. (Dkt. No. 144 at 1-2; Dkt. No. 149 at 6.) An award of attorneys’ fees under 35 U.S.C. § 285 must be “reasonable.” Kilopass Tech., Inc. v. Sidense Corp., 82 F. Supp. 3d 1154, 1164 (N.D. Cal. 2015); see SRI Int’l, Inc. v. Cisco Sys., Inc., 930 F.3d 1295, 1311 (Fed. Cir. 2019) (“Section 285 permits a prevailing party to recover reasonable attorneys’ fees.”). “The requirement that fees awarded be reasonable is a safeguard against excessive reimbursement.” IPS Grp., Inc. v. Duncan Sols., Inc., No. 15-CV-1526-CAB (MDD), 2018 WL 3956019, at *1 (S.D. Cal. Aug. 17, 2018) (citing Mathis v. Spears, 857 F.2d 749, 754 (Fed. Cir. 1988)). In calculating an attorneys’ fee award under § 285, “a district court usually applies the lodestar method, which provides a presumptively reasonable fee amount by multiplying a reasonable hourly rate by the reasonable number of hours required to litigate a comparable case.” Lumen View Tech. LLC v. Findthebest.com, Inc., 811 F.3d 479, 483 (Fed. Cir. 2016) (citing Perdue v. Kenny A. ex rel. Winn, 559 U.S. 542, 551, 554 (2010)); see also Staton v. Boeing Co., 327 F.3d 938, 965 (9th Cir. 2003) (“When a statute provides for such fees, it is termed a ‘fee-shifting’ statute. Under a fee-shifting statute, the court ‘must calculate awards for attorneys’ fees using the ‘lodestar’ method.’”). “Ultimately, a ‘reasonable’ number of hours equals ‘the number of hours which could reasonably have been billed to a private client.’” Gonzalez v. City of Maywood, 729 F.3d 1196, 1202 (9th Cir. 2013) (quoting Moreno v. City of Sacramento, 534 F.3d 1106, 1111 (9th Cir. 2008)). A district court should not award “fees for hours expended by counsel that were ‘excessive, redundant, or otherwise unnecessary.’” SRI, 930 F.3d at 1311 (quoting Hensley v. Eckerhart, 461 U.S. 424, 437 (1983)); accord Gonzalez, 729 F.3d at 1203. “The fee applicant bears the burden of establishing entitlement to an award and documenting the appropriate hours expended and hourly rates.” Hensley, 461 U.S. at 437; see Welch v. Metro. Life Ins. Co., 480 F.3d 942, 945–46 (9th Cir. 2007) (“The party seeking fees bears the

Free access — add to your briefcase to read the full text and ask questions with AI

CliniComp International, Inc. v. Cerner Corporation, (S.D. Cal. 2023).

CliniComp International, Inc. v. Cerner Corporation (CliniComp International, Inc. v. Cerner Corporation) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Hensley v. Eckerhart
461 U.S. 424 (Supreme Court, 1983)
Staton v. Boeing Co.
327 F.3d 938 (Ninth Circuit, 2003)
Welch v. Metropolitan Life Ins. Co.
480 F.3d 942 (Ninth Circuit, 2007)
Martin Gonzalez, Sr. v. City of Maywood
729 F.3d 1196 (Ninth Circuit, 2013)
Moreno v. City of Sacramento
534 F.3d 1106 (Ninth Circuit, 2008)
Lumen View Technology LLC v. Findthebest.com, Inc.
811 F.3d 479 (Federal Circuit, 2016)
Marguerite Hiken v. Department of Defense
836 F.3d 1037 (Ninth Circuit, 2016)
Twum v. Barr
930 F.3d 10 (First Circuit, 2019)
United Steelworkers v. Phelps Dodge Corp.
896 F.2d 403 (Ninth Circuit, 1990)
Gates v. Deukmejian
987 F.2d 1392 (Ninth Circuit, 1992)